Nocturnal Polyuria Treatment Market 2027 By Product, Distribution channel and Geography | The Insight Partners

Nocturnal Polyuria Treatment Market Forecast to 2027 - COVID-19 Impact and Global Analysis By Product (Antispasmodic, Desmopressin, Anticholinergic drugs, Other); Distribution channel (Hospital Pharmacy, Online Pharmacy, Retail Pharmacy, Other) and Geography

Report Code: TIPRE00013984 | No. of Pages: 150 | Category: Pharmaceuticals | Status: Upcoming
Covid
MARKET INTRODUCTION

Nocturnal polyuria (also known as Nocturia) is a medical condition in which patients get frequent urination while sleeping at night. Treatment involves administering drugs based on underlying medical conditions, like neurological disorders, cardiac symptoms, hypertension or intake of medicines, and type of Nocturia such as nocturnal polyuria, mixed Nocturia, and bladder storage problem.

MARKET DYNAMICS

Factors like increasing elderly population with an increasing prevalence of organ failure, rising cases of high salt intake, and hypertension are expected to increase the Nocturnal polyuria treatment market. Further, improving healthcare infrastructure and the diagnostic segment is also driving the chances for Nocturnal polyuria treatment. However, high operation costs and the impact of the Covid19 pandemic may hamper the Nocturnal polyuria treatment market's growth.

MARKET SCOPE

The "Nocturnal Polyuria Treatment Market Analysis to 2027" is a specialized and in-depth study of the healthcare industry with a special focus on the global market trend analysis. The report aims to provide an overview of nocturnal polyuria treatment market with detailed market segmentation by product and end user. Nocturnal polyuria treatment market is expected to witness high growth during the forecast period. The report provides key statistics on the market status of the leading players in nocturnal polyuria treatment and offers key trends and opportunities in the market.

MARKET SEGMENTATION

The nocturnal polyuria treatment market is segmented on the basis of product and distribution channel. Based on product, the global nocturnal polyuria treatment market can be classified as antispasmodic, desmopressin, anticholinergic drugs and other. Based on distribution channel, market is segmented into hospital pharmacy, online pharmacy, retail pharmacy and other.

REGIONAL FRAMEWORK

The report provides a detailed overview of the industry including both qualitative and quantitative information. It provides overview and forecast of the nocturnal polyuria treatment market based on various segments. It also provides market size and forecast estimates from year 2017 to2027with respect to five major regions, namely; North America, Europe, Asia-Pacific (APAC), Middle East and Africa (MEA) and South & Central America. The nocturnal polyuria treatment market by each region is later sub-segmented by respective countries and segments. The report covers analysis and forecast of 18 countries globally along with current trend and opportunities prevailing in the region.

The report analyzes factors affecting nocturnal polyuria treatment market from both demand and supply side and further evaluates market dynamics affecting the market during forecast period i.e., drivers, restraints, opportunities, and future trend. The report also provides exhaustive PEST analysis for all five regions namely; North America, Europe, APAC, MEA and South & Central America after evaluating political, economic, social and technological factors affecting the nocturnal polyuria treatment market in these regions.



Get more information on this report :

MARKET PLAYERS


The report covers key developments in the nocturnal polyuria treatment market as organic and inorganic growth strategies. Various companies are focusing on organic growth strategies such as product launches, product approvals and others such as patents and events. Inorganic growth strategies witnessed in the market were acquisitions, and partnership & collaborations. These activities have paved way for expansion of business and customer base of market players. The market players from nocturnal polyuria treatment market are anticipated to have lucrative growth opportunities in the future with the rising demand for nocturnal polyuria treatment market in the global market. Below mentioned is the list of few companies engaged in nocturnal polyuria treatment market.

The report also includes the profiles of key players in nocturnal polyuria treatment market along with their SWOT analysis and market strategies. In addition, the report focuses on leading industry players with information such as company profiles, components and services offered financial information of last 3 years, key development in past five years.

  •  Teva Pharmaceutical Industries Ltd
  •  Allergan, Inc.
  •  Ferring Holding SA
  •  Vantia Therapeutics
  •  Astellas Pharma Inc.
  •  Urigen Pharmaceuticals, Inc.
  •  Glenmark Pharmaceuticals Limited
  •  AA Pharma Inc.
  •  Avadel Pharmaceuticals
  •  Nexus Pharma Co., Ltd

The Insight Partner's dedicated research and analysis team consists of experienced professionals with advanced statistical expertise and offers various customization options in the existing study.


Get more information on this report :

TABLE OF CONTENTS

1. INTRODUCTION
1.1. SCOPE OF THE STUDY
1.2. THE INSIGHT PARTNERS RESEARCH REPORT GUIDANCE
1.3. MARKET SEGMENTATION
1.3.1 Nocturnal Polyuria Treatment Market - By Product
1.3.2 Nocturnal Polyuria Treatment Market - By Distribution channel
1.3.3 Nocturnal Polyuria Treatment Market - By Region
1.3.3.1 By Country

2. KEY TAKEAWAYS

3. RESEARCH METHODOLOGY

4. NOCTURNAL POLYURIA TREATMENT MARKET LANDSCAPE
4.1. OVERVIEW
4.2. PORTER'S FIVE FORCES ANALYSIS
4.2.1 Bargaining Power of Buyers
4.2.1 Bargaining Power of Suppliers
4.2.1 Threat of Substitute
4.2.1 Threat of New Entrants
4.2.1 Competitive Rivalry
4.3. EXPERT OPINIONS

5. NOCTURNAL POLYURIA TREATMENT MARKET - KEY MARKET DYNAMICS
5.1. KEY MARKET DRIVERS
5.2. KEY MARKET RESTRAINTS
5.3. KEY MARKET OPPORTUNITIES
5.4. FUTURE TRENDS
5.5. IMPACT ANALYSIS OF DRIVERS AND RESTRAINTS

6. NOCTURNAL POLYURIA TREATMENT MARKET - GLOBAL MARKET ANALYSIS
6.1. NOCTURNAL POLYURIA TREATMENT - GLOBAL MARKET OVERVIEW
6.2. NOCTURNAL POLYURIA TREATMENT - GLOBAL MARKET AND FORECAST TO 2027
6.3. MARKET POSITIONING/MARKET SHARE

7. NOCTURNAL POLYURIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - PRODUCT
7.1. OVERVIEW
7.2. PRODUCT MARKET FORECASTS AND ANALYSIS
7.3. ANTISPASMODIC
7.3.1. Overview
7.3.2. Antispasmodic Market Forecast and Analysis
7.4. DESMOPRESSIN
7.4.1. Overview
7.4.2. Desmopressin Market Forecast and Analysis
7.5. ANTICHOLINERGIC DRUGS
7.5.1. Overview
7.5.2. Anticholinergic drugs Market Forecast and Analysis
7.6. OTHER
7.6.1. Overview
7.6.2. Other Market Forecast and Analysis
8. NOCTURNAL POLYURIA TREATMENT MARKET - REVENUE AND FORECASTS TO 2027 - DISTRIBUTION CHANNEL
8.1. OVERVIEW
8.2. DISTRIBUTION CHANNEL MARKET FORECASTS AND ANALYSIS
8.3. HOSPITAL PHARMACY
8.3.1. Overview
8.3.2. Hospital Pharmacy Market Forecast and Analysis
8.4. ONLINE PHARMACY
8.4.1. Overview
8.4.2. Online Pharmacy Market Forecast and Analysis
8.5. RETAIL PHARMACY
8.5.1. Overview
8.5.2. Retail Pharmacy Market Forecast and Analysis
8.6. OTHER
8.6.1. Overview
8.6.2. Other Market Forecast and Analysis

9. NOCTURNAL POLYURIA TREATMENT MARKET REVENUE AND FORECASTS TO 2027 - GEOGRAPHICAL ANALYSIS
9.1. NORTH AMERICA
9.1.1 North America Nocturnal Polyuria Treatment Market Overview
9.1.2 North America Nocturnal Polyuria Treatment Market Forecasts and Analysis
9.1.3 North America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Product
9.1.4 North America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Distribution channel
9.1.5 North America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Countries
9.1.5.1 United States Nocturnal Polyuria Treatment Market
9.1.5.1.1 United States Nocturnal Polyuria Treatment Market by Product
9.1.5.1.2 United States Nocturnal Polyuria Treatment Market by Distribution channel
9.1.5.2 Canada Nocturnal Polyuria Treatment Market
9.1.5.2.1 Canada Nocturnal Polyuria Treatment Market by Product
9.1.5.2.2 Canada Nocturnal Polyuria Treatment Market by Distribution channel
9.1.5.3 Mexico Nocturnal Polyuria Treatment Market
9.1.5.3.1 Mexico Nocturnal Polyuria Treatment Market by Product
9.1.5.3.2 Mexico Nocturnal Polyuria Treatment Market by Distribution channel
9.2. EUROPE
9.2.1 Europe Nocturnal Polyuria Treatment Market Overview
9.2.2 Europe Nocturnal Polyuria Treatment Market Forecasts and Analysis
9.2.3 Europe Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Product
9.2.4 Europe Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Distribution channel
9.2.5 Europe Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Countries
9.2.5.1 Germany Nocturnal Polyuria Treatment Market
9.2.5.1.1 Germany Nocturnal Polyuria Treatment Market by Product
9.2.5.1.2 Germany Nocturnal Polyuria Treatment Market by Distribution channel
9.2.5.2 Italy Nocturnal Polyuria Treatment Market
9.2.5.2.1 Italy Nocturnal Polyuria Treatment Market by Product
9.2.5.2.2 Italy Nocturnal Polyuria Treatment Market by Distribution channel
9.2.5.3 Spain Nocturnal Polyuria Treatment Market
9.2.5.3.1 Spain Nocturnal Polyuria Treatment Market by Product
9.2.5.3.2 Spain Nocturnal Polyuria Treatment Market by Distribution channel
9.2.5.4 United Kingdom Nocturnal Polyuria Treatment Market
9.2.5.4.1 United Kingdom Nocturnal Polyuria Treatment Market by Product
9.2.5.4.2 United Kingdom Nocturnal Polyuria Treatment Market by Distribution channel
9.3. ASIA-PACIFIC
9.3.1 Asia-Pacific Nocturnal Polyuria Treatment Market Overview
9.3.2 Asia-Pacific Nocturnal Polyuria Treatment Market Forecasts and Analysis
9.3.3 Asia-Pacific Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Product
9.3.4 Asia-Pacific Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Distribution channel
9.3.5 Asia-Pacific Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Countries
9.3.5.1 Australia Nocturnal Polyuria Treatment Market
9.3.5.1.1 Australia Nocturnal Polyuria Treatment Market by Product
9.3.5.1.2 Australia Nocturnal Polyuria Treatment Market by Distribution channel
9.3.5.2 China Nocturnal Polyuria Treatment Market
9.3.5.2.1 China Nocturnal Polyuria Treatment Market by Product
9.3.5.2.2 China Nocturnal Polyuria Treatment Market by Distribution channel
9.3.5.3 India Nocturnal Polyuria Treatment Market
9.3.5.3.1 India Nocturnal Polyuria Treatment Market by Product
9.3.5.3.2 India Nocturnal Polyuria Treatment Market by Distribution channel
9.3.5.4 Japan Nocturnal Polyuria Treatment Market
9.3.5.4.1 Japan Nocturnal Polyuria Treatment Market by Product
9.3.5.4.2 Japan Nocturnal Polyuria Treatment Market by Distribution channel
9.3.5.5 South Korea Nocturnal Polyuria Treatment Market
9.3.5.5.1 South Korea Nocturnal Polyuria Treatment Market by Product
9.3.5.5.2 South Korea Nocturnal Polyuria Treatment Market by Distribution channel
9.4. MIDDLE EAST AND AFRICA
9.4.1 Middle East and Africa Nocturnal Polyuria Treatment Market Overview
9.4.2 Middle East and Africa Nocturnal Polyuria Treatment Market Forecasts and Analysis
9.4.3 Middle East and Africa Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Product
9.4.4 Middle East and Africa Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Distribution channel
9.4.5 Middle East and Africa Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Countries
9.4.5.1 South Africa Nocturnal Polyuria Treatment Market
9.4.5.1.1 South Africa Nocturnal Polyuria Treatment Market by Product
9.4.5.1.2 South Africa Nocturnal Polyuria Treatment Market by Distribution channel
9.4.5.2 Saudi Arabia Nocturnal Polyuria Treatment Market
9.4.5.2.1 Saudi Arabia Nocturnal Polyuria Treatment Market by Product
9.4.5.2.2 Saudi Arabia Nocturnal Polyuria Treatment Market by Distribution channel
9.4.5.3 U.A.E Nocturnal Polyuria Treatment Market
9.4.5.3.1 U.A.E Nocturnal Polyuria Treatment Market by Product
9.4.5.3.2 U.A.E Nocturnal Polyuria Treatment Market by Distribution channel
9.5. SOUTH AND CENTRAL AMERICA
9.5.1 South and Central America Nocturnal Polyuria Treatment Market Overview
9.5.2 South and Central America Nocturnal Polyuria Treatment Market Forecasts and Analysis
9.5.3 South and Central America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Product
9.5.4 South and Central America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Distribution channel
9.5.5 South and Central America Nocturnal Polyuria Treatment Market Forecasts and Analysis - By Countries
9.5.5.1 Brazil Nocturnal Polyuria Treatment Market
9.5.5.1.1 Brazil Nocturnal Polyuria Treatment Market by Product
9.5.5.1.2 Brazil Nocturnal Polyuria Treatment Market by Distribution channel
9.5.5.2 Argentina Nocturnal Polyuria Treatment Market
9.5.5.2.1 Argentina Nocturnal Polyuria Treatment Market by Product
9.5.5.2.2 Argentina Nocturnal Polyuria Treatment Market by Distribution channel

10. INDUSTRY LANDSCAPE
10.1. MERGERS AND ACQUISITIONS
10.2. AGREEMENTS, COLLABORATIONS AND JOIN VENTURES
10.3. NEW PRODUCT LAUNCHES
10.4. EXPANSIONS AND OTHER STRATEGIC DEVELOPMENTS

11. NOCTURNAL POLYURIA TREATMENT MARKET, KEY COMPANY PROFILES
11.1. TEVA PHARMACEUTICAL INDUSTRIES LTD
11.1.1. Key Facts
11.1.2. Business Description
11.1.3. Products and Services
11.1.4. Financial Overview
11.1.5. SWOT Analysis
11.1.6. Key Developments
11.2. ALLERGAN, INC.
11.2.1. Key Facts
11.2.2. Business Description
11.2.3. Products and Services
11.2.4. Financial Overview
11.2.5. SWOT Analysis
11.2.6. Key Developments
11.3. FERRING HOLDING SA
11.3.1. Key Facts
11.3.2. Business Description
11.3.3. Products and Services
11.3.4. Financial Overview
11.3.5. SWOT Analysis
11.3.6. Key Developments
11.4. VANTIA THERAPEUTICS
11.4.1. Key Facts
11.4.2. Business Description
11.4.3. Products and Services
11.4.4. Financial Overview
11.4.5. SWOT Analysis
11.4.6. Key Developments
11.5. ASTELLAS PHARMA INC.
11.5.1. Key Facts
11.5.2. Business Description
11.5.3. Products and Services
11.5.4. Financial Overview
11.5.5. SWOT Analysis
11.5.6. Key Developments
11.6. URIGEN PHARMACEUTICALS, INC.
11.6.1. Key Facts
11.6.2. Business Description
11.6.3. Products and Services
11.6.4. Financial Overview
11.6.5. SWOT Analysis
11.6.6. Key Developments
11.7. GLENMARK PHARMACEUTICALS LIMITED
11.7.1. Key Facts
11.7.2. Business Description
11.7.3. Products and Services
11.7.4. Financial Overview
11.7.5. SWOT Analysis
11.7.6. Key Developments
11.8. AA PHARMA INC.
11.8.1. Key Facts
11.8.2. Business Description
11.8.3. Products and Services
11.8.4. Financial Overview
11.8.5. SWOT Analysis
11.8.6. Key Developments
11.9. AVADEL PHARMACEUTICALS
11.9.1. Key Facts
11.9.2. Business Description
11.9.3. Products and Services
11.9.4. Financial Overview
11.9.5. SWOT Analysis
11.9.6. Key Developments
11.10.  NEXUS PHARMA CO., LTD
11.10.1. Key Facts
11.10.2. Business Description
11.10.3. Products and Services
11.10.4. Financial Overview
11.10.5. SWOT Analysis
11.10.6. Key Developments

12. APPENDIX
12.1. ABOUT THE INSIGHT PARTNERS
12.2. GLOSSARY OF TERMS
The List of Companies

1. Teva Pharmaceutical Industries Ltd
2. Allergan, Inc.
3. Ferring Holding SA
4. Vantia Therapeutics
5. Astellas Pharma Inc.
6. Urigen Pharmaceuticals, Inc.
7. Glenmark Pharmaceuticals Limited
8. AA Pharma Inc.
9. Avadel Pharmaceuticals
10. Nexus Pharma Co., Ltd
TIPRE00013984
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Pricing

Free

20%

customization on Pre-Booking